Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 May;84(9):1172–1178. doi: 10.1054/bjoc.2001.1733

Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?

E A Grunfeld 1, A J Ramirez 1, E J Maher 2, D Peach 2, T Young 2, I P Albery 1, M A Richards 1
PMCID: PMC2363889  PMID: 11336466

Abstract

Chemotherapy is widely used in the management of patients with advanced breast cancer. However, a considerable proportion of patients experience toxic side effects without gaining benefit. This study aimed to elicit oncologists' views of the goals of chemotherapy for patients with advanced breast cancer and to elicit which factors are important in decisions to recommend chemotherapy to such patients. 30 oncologists underwent a semi-structured interview to examine their views of 5 goals of chemotherapy and of various disease, treatment and patient-related factors that might influence decisions to offer treatment. The clinicians also made decisions regarding treatment in relation to a hypothetical patient scenario under varying clinical conditions. Relief of symptoms and improvement of activity were rated as the most valuable and achievable goals of treatment. The patient's performance status, frailty and their wishes regarding treatment were the most important patient-related factors in determining decision-making. The most important disease/treatment-related factors were pace of the disease, previous poor response to chemotherapy, co-existing symptoms and concurrent medical conditions. The hypothetical scenario revealed that co-existing medical conditions, adverse previous response, increased age and depression would decrease the likelihood of recommending chemotherapy, whereas key symptoms (e.g. breathlessness) and the patient's goals would increase the likelihood. The findings suggest that British oncologists primarily aim to improve patients' physical function, although subjective factors, such as a patient's desire for anti-cancer treatment and their future goals, also influence decisions to offer treatment. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: palliative chemotherapy, advanced breast cancer, clinical decision-making

Full Text

The Full Text of this article is available as a PDF (117.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benner S. E., Fetting J. H., Brenner M. H. A stopping rule for standard chemotherapy for metastatic breast cancer: lessons from a survey of Maryland medical oncologists. Cancer Invest. 1994;12(5):451–455. doi: 10.3109/07357909409021402. [DOI] [PubMed] [Google Scholar]
  2. Deber R. B., Thompson G. G. Variations in breast cancer treatment decisions and their impact in mounting trials. Control Clin Trials. 1990 Oct;11(5):353–373. doi: 10.1016/0197-2456(90)90176-3. [DOI] [PubMed] [Google Scholar]
  3. Dodwell D. J., Rathmell A. J., Ash D. V. Assessment of palliative chemotherapy: a step beyond response. Clin Oncol (R Coll Radiol) 1993;5(2):114–117. doi: 10.1016/s0936-6555(05)80860-x. [DOI] [PubMed] [Google Scholar]
  4. EDWARDS W. The theory of decision making. Psychol Bull. 1954 Jul;51(4):380–417. doi: 10.1037/h0053870. [DOI] [PubMed] [Google Scholar]
  5. Falkson G., Gelman R., Falkson C. I., Glick J., Harris J. Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. J Clin Oncol. 1991 Dec;9(12):2153–2161. doi: 10.1200/JCO.1991.9.12.2153. [DOI] [PubMed] [Google Scholar]
  6. Geels P., Eisenhauer E., Bezjak A., Zee B., Day A. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol. 2000 Jun;18(12):2395–2405. doi: 10.1200/JCO.2000.18.12.2395. [DOI] [PubMed] [Google Scholar]
  7. Gregory W. M., Smith P., Richards M. A., Twelves C. J., Knight R. K., Rubens R. D. Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer. 1993 Nov;68(5):988–995. doi: 10.1038/bjc.1993.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maher E. J., Coia L., Duncan G., Lawton P. A. Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys. 1992;23(1):239–244. doi: 10.1016/0360-3016(92)90568-3. [DOI] [PubMed] [Google Scholar]
  9. Maher E. J., Jefferis A. F. Decision making in advanced cancer of the head and neck: variation in the views of medical specialists. J R Soc Med. 1990 Jun;83(6):356–359. doi: 10.1177/014107689008300607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Markman M. "Salvage chemotherapy" of malignant disease: importance of precisely defining the goals of treatment. J Cancer Res Clin Oncol. 1997;123(9):467–468. doi: 10.1007/BF01192199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McGuire W. L., Tandon A. K., Allred D. C., Chamness G. C., Ravdin P. M., Clark G. M. Prognosis and treatment decisions in patients with breast cancer without axillary node involvement. Cancer. 1992 Sep 15;70(6 Suppl):1775–1781. doi: 10.1002/1097-0142(19920915)70:4+<1775::aid-cncr2820701619>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  12. Porzsolt F., Tannock I. Goals of palliative cancer therapy. J Clin Oncol. 1993 Feb;11(2):378–381. doi: 10.1200/JCO.1993.11.2.378. [DOI] [PubMed] [Google Scholar]
  13. Ramirez A. J., Towlson K. E., Leaning M. S., Richards M. A., Rubens R. D. Do patients with advanced breast cancer benefit from chemotherapy? Br J Cancer. 1998 Dec;78(11):1488–1494. doi: 10.1038/bjc.1998.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rubens R. D., Towlson K. E., Ramirez A. J., Coltart S., Slevin M. L., Terrell C., Timothy A. R. Appropriate chemotherapy for palliating advanced cancer. BMJ. 1992 Jan 4;304(6818):35–40. doi: 10.1136/bmj.304.6818.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stanton A. L., Estes M. A., Estes N. C., Cameron C. L., Danoff-Burg S., Irving L. M. Treatment decision making and adjustment to breast cancer: a longitudinal study. J Consult Clin Psychol. 1998 Apr;66(2):313–322. doi: 10.1037//0022-006x.66.2.313. [DOI] [PubMed] [Google Scholar]
  17. Stoll B. A. Choosing between cancer patients. J Med Ethics. 1990 Jun;16(2):71–74. doi: 10.1136/jme.16.2.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sutherland H. J., Lockwood G. A., Boyd N. F. Ratings of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer. J Clin Epidemiol. 1990;43(7):661–666. doi: 10.1016/0895-4356(90)90036-o. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES